These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 2751476)
1. Mechanisms of HDL reduction after probucol. Changes in HDL subfractions and increased reverse cholesteryl ester transfer. Franceschini G; Sirtori M; Vaccarino V; Gianfranceschi G; Rezzonico L; Chiesa G; Sirtori CR Arteriosclerosis; 1989; 9(4):462-9. PubMed ID: 2751476 [TBL] [Abstract][Full Text] [Related]
2. Changes in high-density lipoprotein subfraction distribution and increased cholesteryl ester transfer after probucol. Sirtori CR; Sirtori M; Calabresi L; Franceschini G Am J Cardiol; 1988 Jul; 62(3):73B-76B. PubMed ID: 3293417 [TBL] [Abstract][Full Text] [Related]
3. Selective reduction of cholesterol in HDL2 fraction by probucol in familial hypercholesterolemia and hyperHDL2 cholesterolemia with abnormal cholesteryl ester transfer. Matsuzawa Y; Yamashita S; Funahashi T; Yamamoto A; Tarui S Am J Cardiol; 1988 Jul; 62(3):66B-72B. PubMed ID: 3394656 [TBL] [Abstract][Full Text] [Related]
4. Decrease of plasma large, light LDL (LDL1), HDL2 and HDL3 levels with concomitant increase of cholesteryl ester transfer protein (CETP) activity by probucol in type II hyperlipoproteinemia. Homma Y; Kobayashi T; Yamaguchi H; Sakane H; Ozawa H; Matsuda M; Mikami Y; Mikami Y; Nakamura H Artery; 1993; 20(1):1-18. PubMed ID: 8447724 [TBL] [Abstract][Full Text] [Related]
5. Probucol normalizes cholesteryl ester transfer in IDDM. Bagdade JD; Stein E; Ritter MC Diabetes Care; 1995 Oct; 18(10):1341-6. PubMed ID: 8721935 [TBL] [Abstract][Full Text] [Related]
6. Probucol increases cholesteryl ester transfer protein activity in hypercholesterolaemic patients. Franceschini G; Chiesa G; Sirtori CR Eur J Clin Invest; 1991 Aug; 21(4):384-8. PubMed ID: 1936105 [TBL] [Abstract][Full Text] [Related]
7. Increase in plasma cholesteryl ester transfer protein during probucol treatment. Relation to changes in high density lipoprotein composition. McPherson R; Hogue M; Milne RW; Tall AR; Marcel YL Arterioscler Thromb; 1991; 11(3):476-81. PubMed ID: 1903061 [TBL] [Abstract][Full Text] [Related]
11. Opposite effects on serum cholesteryl ester transfer protein levels between long-term treatments with pravastatin and probucol in patients with primary hypercholesterolemia and xanthoma. Inazu A; Koizumi J; Kajinami K; Kiyohar T; Chichibu K; Mabuchi H Atherosclerosis; 1999 Aug; 145(2):405-13. PubMed ID: 10488970 [TBL] [Abstract][Full Text] [Related]
12. A comparison of cholestyramine and probucol in the treatment of familial hypercholesterolaemia. Jones DB; Simpson HC; Slaughter P; Lousley S; Carter RD; Cobbe SM; Mann JI Atherosclerosis; 1984 Oct; 53(1):1-7. PubMed ID: 6388586 [TBL] [Abstract][Full Text] [Related]
13. Modulation of HDL metabolism by probucol in complete cholesteryl ester transfer protein deficiency. Noto H; Kawamura M; Hashimoto Y; Satoh H; Hara M; Iso-o N; Togo M; Kimura S; Tsukamoto K Atherosclerosis; 2003 Nov; 171(1):131-6. PubMed ID: 14642415 [TBL] [Abstract][Full Text] [Related]
14. Enhanced cholesteryl ester transfer protein activities and abnormalities of high density lipoproteins in familial hypercholesterolemia. Inazu A; Koizumi J; Mabuchi H; Kajinami K; Takeda R Horm Metab Res; 1992 Jun; 24(6):284-8. PubMed ID: 1634194 [TBL] [Abstract][Full Text] [Related]
15. Double-blind, placebo-controlled, cross-over trial of probucol in heterozygous familial hypercholesterolaemia. Durrington PN; Miller JP Atherosclerosis; 1985 May; 55(2):187-94. PubMed ID: 3890872 [TBL] [Abstract][Full Text] [Related]
16. Effect of probucol treatment on lipoprotein cholesterol and drug levels in blood and lipoproteins in familial hypercholesterolemia. Fellin R; Gasparotto A; Valerio G; Baiocchi MR; Padrini R; Lamon S; Vitale E; Baggio G; Crepaldi G Atherosclerosis; 1986 Jan; 59(1):47-56. PubMed ID: 3081013 [TBL] [Abstract][Full Text] [Related]
17. Fenofibrate reduces plasma cholesteryl ester transfer from HDL to VLDL and normalizes the atherogenic, dense LDL profile in combined hyperlipidemia. Guérin M; Bruckert E; Dolphin PJ; Turpin G; Chapman MJ Arterioscler Thromb Vasc Biol; 1996 Jun; 16(6):763-72. PubMed ID: 8640404 [TBL] [Abstract][Full Text] [Related]
18. Combined effects of probucol and benzafibrate on lipoprotein metabolism and liver cholesteryl ester transfer protein mRNA in cholesterol-fed rabbits. Ou J; Saku K; Jimi S; Liao YL; Ohta T; Zhang B; Arakawa K Jpn Circ J; 1999 Jun; 63(6):471-7. PubMed ID: 10406588 [TBL] [Abstract][Full Text] [Related]
19. Effects of pancreas transplantation on distribution and composition of plasma lipoproteins. Föger B; Königsrainer A; Palos G; Ritsch A; Tröbinger G; Menzel HJ; Lechleitner M; Doblinger A; König P; Utermann G; Margreiter R; Patsch JR Metabolism; 1996 Jul; 45(7):856-61. PubMed ID: 8692021 [TBL] [Abstract][Full Text] [Related]
20. Effects of probucol on plasma lipids, lipoproteins and parameters of high density lipoprotein metabolism. Wetterau JR; Combs KA; Albers HW; Lamkin G; Stein EA; Barnhart RL; Chi EM; Jackson RL; Harmony JA Horm Metab Res; 1992 Jun; 24(6):289-96. PubMed ID: 1634195 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]